Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2012
08/15/2012CN102210790B Compound agilawood essential oil for releasing tension headache
08/15/2012CN102188500B Traditional Chinese medicine preparation for treating anxiety neurosis
08/15/2012CN102178885B Medicinal composition for sobering
08/15/2012CN101891822B Fusion polypeptide use for preventing and treating senile dementia by brain barrier permeability
08/15/2012CN101850058B Chinese medicament for preventing and treating agrypnia, memory loss and alzheimers disease and method
08/15/2012CN101628086B Gastrodiaelata Blume plant extract for preventing and treating vascular dementia and preparation method thereof
08/15/2012CN101591377B Aminoacyl-phenylalanyl-tryptophan or derivative, synthetic method and application thereof
08/15/2012CN101489559B Purine and deazapurine derivatives as pharmaceutical compounds
08/15/2012CN101366874B Medicament composition for preventing birth defect and improving memory
08/15/2012CN101366803B Medicament composition for preventing birth defect and improving memory
08/15/2012CN101366802B Medicament composition for preventing birth defect and improving memory
08/15/2012CN101307046B Tripeptidyl peptidase inhibitors
08/15/2012CN101304979B Quinazoline derivative and pharmaceutical
08/15/2012CN101265297B Alpha-synapse nucleoprotein and Sph1 interactive condition site and application thereof in screening Parkinson's disease medicament
08/15/2012CN101062919B 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
08/14/2012US8242147 Aryl ureas with angiogenisis inhibiting activity
08/14/2012US8242143 Thiazolyl mGluR5 antagonists and methods for their use
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012US8242117 5-membered heterocycle-based p38 kinase inhibitors
08/14/2012US8242088 Carrier vectors through an epithelium with tight junctions
08/14/2012US8241668 Polymers contqining ester, thioester or amide groups in backbone which degrade into bioactive material upon hydrolysis
08/14/2012US8241665 Chewable soft capsule
08/14/2012US8241650 Diabetic neuropathy, antiulcer agents; nitric oxide elution polymer
08/14/2012US8241641 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012CA2740247A1 4-hydroxybutyric acid analogs
08/14/2012CA2732479A1 4-hydroxybutyric acid analogs
08/14/2012CA2684571C Novel therapeutic uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine
08/14/2012CA2544649C Morpholine derivatives as norepinephrine reuptake inhibitors
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/14/2012CA2407905C Antibodies capable to selectively detect prion prpsc isoforms
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/14/2012CA2383509C Use of nicotine or derivatives thereof in a medicine for treating neurological diseases, in particular parkinson disease
08/14/2012CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/09/2012WO2012106524A2 Diagnosis and treatment of the prodromal schizophrenic state
08/09/2012WO2012106499A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/09/2012WO2012106404A2 Diagnosis and treatment of neurological disorders through vipr2 and vpac2r
08/09/2012WO2012106393A2 Withanolide isolated from physalis longifolia and analogs and methods of use thereof
08/09/2012WO2012106363A2 Treatment of tauopathies
08/09/2012WO2012105813A2 Use of icam-1 for prevention or treatment of neurological diseases
08/09/2012WO2012105715A1 Novel external preparation
08/09/2012WO2012105635A1 2-oxy-substituted 8-oxodihydropurine derivative
08/09/2012WO2012105624A1 Transdermal patch
08/09/2012WO2012105623A1 Production method for adhesive patch
08/09/2012WO2012105622A1 Patch preparation
08/09/2012WO2012105588A1 Tetrahydroisoquinoline derivative
08/09/2012WO2012105573A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND α-GLUCOSIDASE INHIBITOR COMPRISING SAME
08/09/2012WO2012105476A1 Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent
08/09/2012WO2012104852A1 Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
08/09/2012WO2012104782A1 Pyrrole derivatives used as modulators of alpha7 nachr
08/09/2012WO2012104569A1 Composition of monoterpenoids for the treatment of cancer
08/09/2012WO2012104568A1 Compositions of monoterpenoids for stimulating the immune system
08/09/2012WO2012104293A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
08/09/2012WO2012104224A1 Caspase-2 inhibitors
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012WO2012103583A1 Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof.
08/09/2012WO2012103577A1 Biomarker for motor neuron disease (mnd)
08/09/2012WO2012081831A3 Composition comprising the extract of loranthus yadoriki sieb having monoamine oxidase-inhibiting activity
08/09/2012WO2012076916A8 Therapeutic association of 5 - hydroxy - tryptophan and caffeine for the treatment of the symptom of parkinson's disease, daytime sleepiness
08/09/2012WO2012068332A9 Methods for treating early stage or mild neurological disorders
08/09/2012WO2012048294A3 Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
08/09/2012WO2012021788A3 Dipeptide calpain inhibitors
08/09/2012WO2012019113A3 Inhibitors of erk for developmental disorders of neuronal connectivity
08/09/2012WO2012004588A3 Therapeutic agents 976
08/09/2012WO2011133790A3 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
08/09/2012US20120204281 Drg11-responsive (dragon) gene family
08/09/2012US20120204280 Drg11-responsive (dragon) gene family
08/09/2012US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis
08/09/2012US20120204275 Apoe immunotherapy
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120202880 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202879 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202876 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/09/2012US20120202870 Treatment of inflammatory diseases using mir-124
08/09/2012US20120202869 Antidepressant Oral Pharmaceutical Compositions
08/09/2012US20120202866 Buccal, polar and non-polar spray containing ondansetron
08/09/2012US20120202865 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202860 Analgesic Compounds, Compositions and Uses Thereof
08/09/2012US20120202856 Substituted benzimdazole derivatives useful as trpm8 receptor modulators
08/09/2012US20120202852 Heterocycle amide t-type calcium channel antagonists
08/09/2012US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202846 Molecular target of neurotoxicity
08/09/2012US20120202842 2-heteroarylcarboxylic acid amides
08/09/2012US20120202839 Methods and compositions for deterring abuse of orally administered pharmaceutical products
08/09/2012US20120202838 Drug formulations
08/09/2012US20120202837 Spirocyclic piperidine derivatives useful as renin inhibitors
08/09/2012US20120202836 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202828 Fused aminodihydropyrimidone derivatives
08/09/2012US20120202824 Pyrazines as delta opioid receptor modulators
08/09/2012US20120202821 Conformationally constrained, fully synthetic macrocyclic compounds
08/09/2012US20120202816 Novel compounds
08/09/2012US20120202810 Substituted 4-aminocyclohexane derivatives
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202807 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202804 Fused aminodihydro-oxazine derivatives
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 1833